期刊文献+

高效液相色谱法测定盐酸度洛西汀肠溶片的R-异构体 被引量:2

Determination of R-isomer in duloxetine hydrochloride enteric-coated tablets by HPLC
下载PDF
导出
摘要 目的建立HPLC法测定盐酸度洛西汀肠溶片R-异构体的方法。方法色谱柱:手性AD-H柱(0.46cm×25cm);流动相:正己烷-异丙醇-二已胺(97.8∶2∶0.2),流速:1.0mL·min-1,检测波长:294nm。结果盐酸度洛西汀R-异构体在2.41~48.20μg·mL-1,色谱峰面积与浓度呈良好的线性关系,r=0.9999,盐酸度洛西汀与其R-异构体的分离度达8.52。结论该方法准确度高、专属性强,可用于盐酸度洛西汀的质量控制。 Objective To establish the determination method for R-isomer in duloxetine hydrochloride enteric-coated tablets by HPLC. Methods The analytical column was chiral AD-H column (0. 46 cm× 25 cm). The mobile phase was n hexane-iso-propanol-diethylamine (97.8 :2 : 0.2). The flow rate was 1.0 mL ·min^-1 and the detective wavelength was 294 nm. Results The calibration curve was linear at 2.41-48. 20 μg · mL^-1 , r=0. 999 9. The resolution between duloxetine hydrochloride and its R-isomer reached 8. 52. Conclusion This method is simple, accurate, sensitive and suitable for the quality control of R-isomer in duloxetine hydrochloride.
作者 施友玲
出处 《中南药学》 CAS 2008年第2期201-203,共3页 Central South Pharmacy
关键词 盐酸度洛西汀肠溶片 R-异构体 高效液相色谱 定量分析 duloxetine hydrochloride R-isomer HPLC content
  • 相关文献

参考文献7

二级参考文献37

  • 1温新民,毛庆华,汤建,虞心红.度洛西汀的合成进展[J].合成化学,2004,12(6):551-554. 被引量:11
  • 2高丽梅,朱凤昌,宋丹青.盐酸度洛西汀的合成[J].中国新药杂志,2005,14(1):74-76. 被引量:10
  • 3FDA.[EB/OL],http://www.accessdata.fda.gov/scripts/oder/drugsatfda/idex.cfm?fuseaction=Search.Overview&DrugName=CYMBALTA,2005-02-18/2005-03-16
  • 4FDA.[EB/OL].http://www.fda.gov/cder/foi/label/2004/21733lbl.pdf,2004-09-29/2005-03-16.
  • 5CHALON S A,GRANIER L A,VANDENHENDE F R,et al.Duloxetine increases serotonin and norepinephrine availability in healthy subjects:a double-blind,controlled study[J].Neuropsychopharmacology,2003,28(9):1685-1693.
  • 6CACCIA S.Metabolism of the newest antidepressants:comparisons with related predecessors[J].Ther Drugs,2004,7(2):143-150.
  • 7SHARMA A,GOLDBERG M J,CERIMELE B J.Phamacokinetics and safety of duloxetine,a dual-serotonin and norepinephrine reuptake inhibitor[J].Clin Pharmacol,2000,40(2):161-167.
  • 8DETKE M J,LU Y,GOLDSTEIN D J,et al.Duloxetine,60 mg once daily,for major depressive disorder:a randomized double-blind placebocontrolled trial[J].Clin Psychiatry,2002,63(4):308-315.
  • 9GOLDSTEIN D J,MALLINCKRODT C H,FERGUSON M B.Duloxetine in the long-term treatment of major depressive disorder.Raskin[J].Clin Psychiatry,2003,64(10):1237-1244.
  • 10VIKTRUP L,PANGALLO B A,DETKE M J,et al.Urinary side effects of duloxetine in the treatment of depression and stress urinary incontinence.[J].Lin Psychiatry,2004,6(2):65-73.

共引文献23

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部